Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 21% ± 2% |
Insufficient scRNA-seq data for expression of GNB1L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 333.12 | 170 / 170 | 100% | 4.47 | 457 / 459 |
brain | 99% | 272.03 | 2621 / 2642 | 100% | 2.97 | 703 / 705 |
esophagus | 100% | 294.58 | 1444 / 1445 | 99% | 3.39 | 181 / 183 |
bladder | 100% | 361.00 | 21 / 21 | 97% | 4.52 | 491 / 504 |
prostate | 100% | 327.85 | 245 / 245 | 97% | 2.47 | 488 / 502 |
skin | 100% | 459.27 | 1809 / 1809 | 97% | 3.64 | 458 / 472 |
intestine | 100% | 282.29 | 966 / 966 | 96% | 4.10 | 506 / 527 |
ovary | 100% | 267.74 | 180 / 180 | 95% | 2.71 | 408 / 430 |
lung | 100% | 251.86 | 577 / 578 | 95% | 3.63 | 1097 / 1155 |
stomach | 98% | 169.86 | 353 / 359 | 93% | 3.67 | 267 / 286 |
thymus | 100% | 258.54 | 652 / 653 | 91% | 3.13 | 553 / 605 |
breast | 100% | 307.32 | 459 / 459 | 91% | 2.44 | 1012 / 1118 |
pancreas | 99% | 165.09 | 325 / 328 | 90% | 2.60 | 161 / 178 |
liver | 97% | 118.60 | 220 / 226 | 83% | 2.11 | 336 / 406 |
kidney | 100% | 186.71 | 89 / 89 | 78% | 1.34 | 699 / 901 |
adrenal gland | 100% | 167.88 | 258 / 258 | 55% | 1.09 | 126 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.05 | 29 / 29 |
spleen | 100% | 485.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.17 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.34 | 1 / 1 |
adipose | 100% | 261.40 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 253.81 | 1333 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 2.84 | 79 / 80 |
muscle | 98% | 160.90 | 788 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 276.78 | 903 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 133.00 | 811 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006974 | Biological process | DNA damage response |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003674 | Molecular function | molecular_function |
Gene name | GNB1L |
Protein name | Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF) G protein subunit beta 1 like |
Synonyms | KIAA1645 WDR14 GY2 FKSG1 |
Description | FUNCTION: Acts as a critical regulator of DNA damage response (DDR) signaling via specifically regulating phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. . |
Accessions | Q9BYB4 ENST00000329517.11 [Q9BYB4-1] C9JPQ6 ENST00000405009.5 [Q9BYB4-2] ENST00000403325.5 [Q9BYB4-1] ENST00000453108.1 |